YBGJ Yubo International Biotech Limited

Fundamentals / CIK 0000895464 / USD

Yubo International Biotech Limited reported $12K in revenue and a net loss of $970K for the trailing twelve months ended September 30, 2026 (up 256.0% year over year), with a 66.1% gross margin and a -8232.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open YBGJ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$1.41M$707K$0-$1.77MFY 2017 Revenue: $0FY 2017 Net Income: -$224K2017FY 2018 Revenue: $0FY 2018 Net Income: -$144K2018FY 2019 Revenue: $0FY 2019 Net Income: -$148K2019FY 2020 Revenue: $0FY 2020 Net Income: -$134K2020FY 2020 Net Income: -$712K2020FY 2021 Revenue: $1.24MFY 2021 Net Income: -$1.54M2021FY 2022 Revenue: $104KFY 2022 Net Income: -$1.20M2022FY 2023 Revenue: $605KFY 2023 Net Income: -$1.20M2023FY 2024 Revenue: $3.5KFY 2024 Net Income: -$1.78M2024FY 2025 Revenue: $12KFY 2025 Net Income: -$1.08M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Feb 29 Feb 28 Feb 28 Feb 28
Revenue $12K $3.5K $605K $104K $1.24M -- $0 $0 $0 $0
Cost of Revenue $4.2K $822 $185K $52K $424K $114K -- -- -- --
Gross Profit $8.2K $2.6K $419K $53K $821K $1.24M -- -- -- --
Selling, General & Admin -- -- -- -- -- -- $29K $48K $58K $149K
Total Operating Expenses $1.20M $1.77M $1.61M $1.26M $2.36M $1.95M -- -- -- --
Operating Income -$1.19M -$1.77M -$1.19M -$1.21M -$1.54M -$712K -$29K -$48K -$58K -$149K
EBITDA -$1.02M -$1.60M -$1.02M -$1.19M -$1.53M -$699K -- -- -- --
Interest Expense -- -- -- -- -- -- $105K $100K $86K $75K
Income Before Tax -$1.19M -$1.98M -$1.20M -$1.20M -$1.54M -- -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$1.08M -$1.78M -$1.20M -$1.20M -$1.54M -$712K -$134K -$148K -$144K -$224K
Basic EPS -- -- -- -- -- -- -$0.11 -$0.13 -$0.12 -$0.19
Diluted EPS -$0.01 -$0.02 -$0.10 -- -- -- -$0.11 -$0.13 -$0.12 -$0.19
Basic Shares Outstanding -- -- -- -- -- -- 1.2M 1.2M 1.2M 1.2M
Diluted Shares Outstanding 139.6M 119.8M 12.0M -- -- -- 1.2M 1.2M 1.2M 1.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $12K $0 $0 $0 -$18
Cost of Revenue $0 $0 $0 $4.2K $0 $0 $0 -$5
Gross Profit $0 $0 $0 $8.2K $0 $0 $0 -$13
Total Operating Expenses $203K $239K $289K $294K $310K $250K $467K $357K
Operating Income -$203K -$239K -$289K -$285K -$310K -$250K -$467K -$357K
EBITDA -$203K -$238K -$264K -$243K -$268K -$208K -$426K -$318K
Interest Expense -- -- -- -- $18 $23 -- --
Income Before Tax -$204K -$269K -$295K -$286K -$310K -$250K -$467K -$353K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$188K -$248K -$273K -$261K -$277K -$230K -$436K -$147K
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted Shares Outstanding 170.4M 170.4M 170.4M -- 147.9M 119.8M 119.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Feb 29 Feb 28
Cash & Cash Equivalents $8.1K $7.0K $6.4K $18K $28K $1.38M $1.0K $4.0K
Cash & Short-Term Investments $8.1K $7.0K $6.4K $18K $28K $1.38M $1.0K $4.0K
Accounts Receivable, Net $138K $165K $80K $52K $162K $2.3K -- --
Inventory $24K $37K $215K $322K $164K $67K -- --
Total Current Assets $668K $683K $725K $750K $1.06M $1.91M $1.0K $4.0K
Property, Plant & Equipment, Net $43K $206K $375K $617K $644K $79K -- --
Intangible Assets $42K $51K $54K $68K $39K $55K -- --
Total Non-Current Assets $180K $852K $942K $1.60M $3.53M $536K $0 $0
Total Assets $847K $1.53M $1.67M $2.35M $4.59M $2.44M $1.0K $4.0K
Accounts Payable -- -- -- -- -- -- $353K $342K
Total Current Liabilities $2.79M $4.72M $3.40M $2.52M $2.79M $1.28M $1.80M $1.67M
Total Non-Current Liabilities $0 $111K $116K $390K $1.93M $0 $0 $0
Total Liabilities $2.79M $4.83M $3.51M $2.91M $4.72M $1.28M $1.80M $1.67M
Total Debt (incl. Leases) $79K $479K $392K $790K $294K $315K -- --
Common Stock -- -- -- -- -- -- -- $1.0K
Retained Earnings -$7.74M -$6.66M -$4.89M -$3.69M -$2.49M -$943K -$29.09M -$28.95M
Accumulated Other Comp. Income $146K $127K -$13K $70K $118K $2.0K -- --
Total Stockholders' Equity -$1.95M -$3.42M -$1.84M -$565K -$131K $1.17M -$1.80M -$1.66M
Total Equity -$1.94M -$3.30M -$1.84M -$565K -$131K $1.17M -$1.80M -$1.66M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- $12K $10K $8.1K $11K $10K $9.8K $7.0K
Cash & Short-Term Investments -- $12K $10K $8.1K $11K $10K $9.8K $7.0K
Accounts Receivable, Net $123K $138K $134K $138K $114K $118K $147K $165K
Inventory $22K $25K $24K $24K $38K $38K $37K $37K
Total Current Assets $579K $583K $598K $668K $650K $659K $685K $683K
Property, Plant & Equipment, Net $17K $17K $18K $43K $85K $126K $166K $206K
Intangible Assets $39K $40K $39K $42K $43K $45K $48K $51K
Total Non-Current Assets $72K $89K $112K $180K $304K $392K $481K $852K
Total Assets $651K $672K $710K $847K $953K $1.05M $1.17M $1.53M
Total Current Liabilities $3.55M $3.33M $3.02M $2.79M $2.56M $5.03M $4.78M $4.72M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $7.8K $31K $111K
Total Liabilities $3.55M $3.33M $3.02M $2.79M $2.56M $5.03M $4.81M $4.83M
Total Debt (incl. Leases) -- $16K $39K $79K $139K $185K $231K $479K
Retained Earnings -$8.45M -$8.26M -$8.01M -$7.74M -$7.48M -$7.33M -$7.10M -$6.66M
Accumulated Other Comp. Income -$40K -$1.3K $76K $146K $176K $217K $318K $127K
Total Stockholders' Equity -$2.85M -$2.62M -$2.30M -$1.95M -$1.66M -$4.00M -$3.67M -$3.42M
Total Equity -$2.90M -$2.66M -$2.31M -$1.94M -$1.60M -$3.86M -$3.65M -$3.30M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Feb 29 Feb 28 Feb 28 Feb 28
Net Income -$1.19M -$1.98M -$1.20M -$1.20M $1.54M -$712K -$134K -$148K -$144K -$224K
Depreciation & Amortization $168K $170K $178K $18K $13K $13K -- -- -- --
Change in Receivables $27K -$85K -$28K -$110K $160K $2.3K -- -- -- --
Change in Inventory $13K $178K $108K $158K -$97K $67K -- -- -- --
Operating Cash Flow -$843K -$1.34M -$739K -$601K -$1.02M $101K -$22K -$32K -$55K -$55K
Capital Expenditure -- -- -- $0 -$565K -$43K -- -- -- --
Free Cash Flow -- -- -- -$601K -$1.59M $59K -- -- -- --
Investing Cash Flow $0 $118K $0 -$40K -$565K -$97K $0 $0 $0 $0
Financing Cash Flow $850K $1.41M $746K $669K $127K $1.38M $19K $34K $56K $45K
Net Change in Cash $1.0K $656 -$12K -$9.3K -$1.36M $1.38M -$3.0K $2.0K $1.0K -$10K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$204K -$269K -$295K -$286K -$310K -$250K -$467K -$353K
Depreciation & Amortization $650 $793 $26K $43K $42K $42K $42K $39K
Change in Receivables $15K -$3.8K $3.8K -$24K $3.7K $29K $18K --
Change in Inventory -- $0 $0 -- -- -$438 -$259 $186K
Operating Cash Flow -$157 -$84K -$207K -$129K -$308K -$14K -$392K -$933K
Capital Expenditure -- -- $0 -- -- -- -$6.2K --
Free Cash Flow -- -- -$207K -- -- -- -$398K --
Investing Cash Flow $0 $0 $0 -$80K $0 $86K -$6.2K $0
Financing Cash Flow $11K $77K $215K $376K $0 $196K $278K $1.11M
Net Change in Cash -$2.5K $1.6K $2.3K -$2.9K $510 $643 $2.8K -$1.0K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Feb 29 Feb 28 Feb 28 Feb 28
Gross Margin 66.1% 76.3% 69.3% 50.5% 65.9% -- -- -- -- --
Operating Margin -9614.6% -51006.3% -197.6% -1155.7% -124.0% -- -- -- -- --
Net Profit Margin -8736.7% -51171.4% -197.6% -1155.5% -124.0% -- -- -- -- --
Return on Equity (ROE) -- -- -- -- -- -61.0% -- -- -- --
Return on Assets (ROA) -127.4% -115.7% -71.7% -51.3% -33.6% -29.1% -13400.0% -3700.0% -- --
Current Ratio 0.24x 0.14x 0.21x 0.30x 0.38x 1.49x 0.00x 0.00x -- --
Quick Ratio 0.23x 0.14x 0.15x 0.17x 0.32x 1.44x 0.00x 0.00x -- --
Debt to Equity -- -- -- -- -- 0.27x -- -- -- --
Revenue Growth (YoY) +256.0% -99.4% +479.8% -91.6% -- -- -- -- -- --
Gross Profit Growth (YoY) +208.3% -99.4% +696.1% -93.6% -33.8% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -1109.7% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -2808.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 66.1% 66.1% 66.1% 66.1% -- -- -- 76.3%
Operating Margin -8232.7% -9096.9% -9184.6% -10625.8% -- -- -- -51006.3%
Net Profit Margin -7855.2% -8570.8% -8428.2% -9747.9% -- -- -- -48201.8%
Return on Assets (ROA) -149.0% -157.5% -146.7% -142.2% -114.3% -136.3% -148.4% -109.0%
Current Ratio 0.16x 0.18x 0.20x 0.24x 0.25x 0.13x 0.14x 0.14x
Quick Ratio 0.16x 0.17x 0.19x 0.23x 0.24x 0.12x 0.14x 0.14x
Revenue Growth (YoY) -- -- -- -- -- -- -100.0% -100.1%
Gross Profit Growth (YoY) -- -- -- -- -- -- -100.0% -100.1%
Operating Cash Flow Growth (YoY) -- -- -- -- -187.2% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0000895464) · from August 31, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal